DSPE-PEG (2000) -Mannose

DSPE-PEG (2000) -Mannose can be used to construct liposome vaccines to improve the anti-tumor effect of vaccines[1].

Product Specifications

CAS Number

[1829524-73-3]

UNSPSC

12352200

Target

Biochemical Assay Reagents

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

90.0

Solubility

DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CCCCCCCCCCCCCCCCCC(O[C@@H](COP(OCCNC(OCCOCCNC(NC1=CC=C(O[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=C1)=S)=O)(O)=O)COC(CCCCCCCCCCCCCCCCC)=O)=O.[n]

Molecular Weight

2000 (Average)

References & Citations

[1]Zhao Y, et al. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. Int J Nanomedicine. 2020 Dec 1;15:9571-9586.